05/29/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities |  |
05/28/2019
6:00 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2019
6:00 PM | Fundaro Paolo (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2019
6:00 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2019
6:00 PM | Benatti Luca (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Sullivan Ryan T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2019
6:00 PM | AKKARAJU SRINIVAS (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2019
4:09 PM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2019
5:02 AM | Intercept Pharmaceuticals (Filer)
| Form 305B2
| |
05/10/2019
6:00 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2019
4:27 PM | Intercept Pharmaceuticals (Filer)
| Form 424B5
| |
05/10/2019
4:23 PM | Intercept Pharmaceuticals (Filer)
| Form 424B5
| |
05/10/2019
7:30 AM | Intercept Pharmaceuticals (Subject)
| Form FWP
| |
05/08/2019
4:22 PM | Intercept Pharmaceuticals (Filer)
| Form 424B5
| |
05/08/2019
4:17 PM | Intercept Pharmaceuticals (Filer)
| Form 424B5
| |
05/08/2019
3:02 PM | Intercept Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2019
6:21 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2019
3:05 PM | Intercept Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/29/2019
6:00 PM | AKKARAJU SRINIVAS (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2019
6:01 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2019
4:01 PM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2019
6:01 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
6:01 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
6:01 PM | Bright Lisa (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
6:01 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
6:00 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2019
6:00 PM | Fundaro Paolo (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2019
3:31 PM | Intercept Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2019
6:32 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2019
6:00 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2019
4:00 PM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2019
7:33 PM | AKKARAJU SRINIVAS (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2019
8:01 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
6:01 PM | Intercept Pharmaceuticals (Issuer)
Sullivan Ryan T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
6:00 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
5:25 AM | Intercept Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/11/2019
6:00 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2019
10:06 AM | BlackRock Inc. (Filed by)
Intercept Pharmaceuticals (Subject)
| Form SC 13G
| |
01/18/2019
6:05 PM | Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:04 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:04 PM | Intercept Pharmaceuticals (Issuer)
Sullivan Ryan T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:04 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:03 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:03 PM | Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:02 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:01 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:00 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2019
6:00 PM | Bright Lisa (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2019
6:00 PM | Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2019
4:01 PM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2019
7:00 PM | Bright Lisa (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2019
6:01 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:04 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:04 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:03 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:03 PM | Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:02 PM | Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:02 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:01 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2019
6:00 PM | Bright Lisa (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2018
6:00 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2018
6:00 PM | Cawkwell Gail (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/07/2018
1:52 PM | Intercept Pharmaceuticals (Subject)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A
| |
12/06/2018
6:00 PM | Bright Lisa (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2018
3:34 PM | Intercept Pharmaceuticals (Issuer)
Micheli Francesco (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2018
3:31 PM | Genextra S.p.A. (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2018
6:00 PM | Intercept Pharmaceuticals (Issuer)
Weyer Christian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
6:01 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2018
6:00 PM | Bright Lisa (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2018
6:00 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2018
6:00 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2018
6:01 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2018
4:01 PM | Intercept Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2018
6:32 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2018
6:00 PM | Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2018
6:00 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2018
6:01 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
6:03 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
6:02 PM | Intercept Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
6:02 PM | Bright Lisa (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
6:01 PM | Intercept Pharmaceuticals (Issuer)
Kapadia Sandip (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
6:01 PM | Durso Jerome Benedict (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
6:00 PM | Ford David A (Reporting)
Intercept Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2018
6:00 PM | Intercept Pharmaceuticals (Issuer)
Pruzanski Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2018
10:10 AM | Intercept Pharmaceuticals (Filer)
| Form CT ORDER
| |
09/07/2018
5:00 PM | Intercept Pharmaceuticals (Issuer)
Shapiro David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2018
3:08 PM | Intercept Pharmaceuticals (Filer)
| Form CT ORDER
| |
08/07/2018
4:01 PM | Intercept Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2018
6:28 AM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/27/2018
4:02 PM | Intercept Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/25/2018
4:00 PM | Intercept Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2018
4:04 PM | Intercept Pharmaceuticals (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
